IT IS hard to understand exactly what is going on inside Malin Corp, the hotchpotch pharmaceutical investment holding company that Kelly Martin set up eight years ago before bailing two years later. What is clear is that Malin is in trouble as the value of its assets has plummeted, with a cash cushion looking like… Read more »
To access this content, you must be a Phoenix subscriber.
Get access to The Phoenix online for as low as €1.50 per week. Read all the regular online only Phoenix stories AND receive the packed digital edition every fortnight (25 per year). Great value for so many inside stories!